Search Results - "Maini, Luca"

Substitutes for Success? Public Versus Private Competition in Medicare Advantage.

Authors: Layton, Tim Maini, Luca McWilliams, J. Michael

Source: Journal of Economic Perspectives. Spring2026, Vol. 40 Issue 2, p143-170. 28p.

Demand Inertia and the Hidden Impact of Pharmacy Benefit Managers.

Authors: Feng, Josh Maini, Luca

Source: Management Science (INFORMS). Dec2024, Vol. 70 Issue 12, p8940-8961. 22p.

Medicaid's GENEROUS Most-Favored-Nation Pricing Model -- Promise and Limitations.

Authors: Maini, Luca Sachs, Rachel E. Kyle, Michael Anne et al.

Source: New England Journal of Medicine. 5/7/2026, Vol. 394 Issue 18, p1772-1774. 3p.

Benefit Design And Biosimilar Coverage In Medicare Part D: Evidence And Implications From Recent Reforms.

Authors: Bertuzzi, Luca Maini, Luca

Source: Health Affairs. May2024, Vol. 43 Issue 5, p717-724. 8p.

Improved Insurance Coverage Increased Biosimilar Semglee's Market Share After The FDA's Interchangeability Designation.

Authors: Kakani, Pragya Katcher, Bradley A. Maini, Luca

Source: Health Affairs. Nov2025, Vol. 44 Issue 11, p1417-1425. 9p.

Impact of Including Drug Spending in Oncology Alternative Payment Models.

Authors: Maini, Luca Klimek, Jacob P. Johnson, David C. et al.

Source: American Journal of Managed Care. Nov2023, Vol. 29 Issue 11, p579-584. 6p.

Challenges in Delivering Most-Favored-Nation Pricing for Prescription Drugs in the US.

Authors: Hwang, Thomas J. Maini, Luca

Source: JAMA: Journal of the American Medical Association. 9/2/2025, Vol. 334 Issue 9, p763-764. 2p.

Profiting from Most-Favored Customer Procurement Rules: Evidence from Medicaid.

Authors: Feng, Josh Maini, Luca Hwang, Thomas

Source: Academy of Management Annual Meeting Proceedings. 2021, Vol. 2021 Issue 1, p1-1. 1p.

Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates.

Authors: Kakani, Pragya Kyle, Michael Anne Chandra, Amitabh et al.

Source: Health Affairs. Oct2024, Vol. 43 Issue 10, p1420-1427. 8p.

Price Regulation in the Pharmaceutical Market

Authors: Maini, Luca

Committee Members: Pakes, Ariel; Cutler, David; Lee, Robin; Berndt, Ernst

URL: http://nrs.harvard.edu/urn-3:HUL.InstRepos:40050065

Medicaid Expenditures and Estimated Rebates on Line Extension Drugs, 2010-2018.

Authors: Hwang, Thomas J. Feng, Josh Maini, Luca et al.

Source: JGIM: Journal of General Internal Medicine. Nov2022, Vol. 37 Issue 14, p3769-3771. 3p. 1 Chart, 1 Graph.

Has The Era Of Slow Growth For Prescription Drug Spending Ended?

Authors: Aitken, Murray Berndt, Ernst R. Cutler, David et al.

Source: Health Affairs. Sep2016, Vol. 35 Issue 9, p1595-1603. 9p.

Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017.

Authors: Hwang, Thomas J. Dusetzina, Stacie B. Feng, Josh et al.

Source: JAMA: Journal of the American Medical Association. 7/16/2019, Vol. 322 Issue 3, p267-269. 3p.

Medicare Part D Savings Under the Manufacturer Discount Program vs Coverage Gap Discounts.

Authors: Rome BN Garrett KR Maini L

Source: JAMA network open [JAMA Netw Open] 2025 Sep 02; Vol. 8 (9), pp. e2530778. Date of Electronic Publication: 2025 Sep 02.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE; In Process

Trends in prescription drug coverage restrictions in Medicare, Medicaid, and commercial insurance plans, 2011-2019.

Authors: Kyle MA Kakani P Burn SL et al.

Source: Health affairs scholar [Health Aff Sch] 2026 Mar 10; Vol. 4 (3), pp. qxag059. Date of Electronic Publication: 2026 Mar 10 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press on behalf of Project HOPE - The People-To-People Health Foundation, Inc Country of Publication: England NLM ID: 9918627882906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2976-5390 (Electronic) Linking ISSN: 29765390 NLM ISO Abbreviation: Health Aff Sch Subsets: PubMed not MEDLINE

Savings from biosimilars and Medicare formulary access.

Authors: Axelsen K Courmier D Bai G et al.

Source: Health affairs scholar [Health Aff Sch] 2025 Nov 12; Vol. 3 (11), pp. qxaf214. Date of Electronic Publication: 2025 Nov 12 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press on behalf of Project HOPE - The People-To-People Health Foundation, Inc Country of Publication: England NLM ID: 9918627882906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2976-5390 (Electronic) Linking ISSN: 29765390 NLM ISO Abbreviation: Health Aff Sch Subsets: PubMed not MEDLINE

Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition.

Authors: Feng K Russo M Maini L et al.

Source: JAMA health forum [JAMA Health Forum] 2024 Mar 01; Vol. 5 (3), pp. e235429. Date of Electronic Publication: 2024 Mar 01.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101769500 Publication Model: Electronic Cited Medium: Internet ISSN: 2689-0186 (Electronic) Linking ISSN: 26890186 NLM ISO Abbreviation: JAMA Health Forum Subsets: MEDLINE